RNS Number : 3020B
NetScientific PLC
15 June 2016
 

 

 

("NetScientific" or the "Company" or the "Group")

 

Results of Annual General Meeting

 

London, UK - 15th June 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic biomedical and healthcare technology  group, announces that all resolutions proposed at today's Annual General Meeting, were duly passed.

 

NetScientific has over the past year undergone a transformation, with a rationalisation of its portfolio and restructuring of the management team, resulting in a streamlined group focused on holding majority positions and delivery and maximising shareholder value from its investments in digital health, diagnostics and therapeutics.

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

Investec (NOMAD and broker)

Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.  For more information, please visit the website at www.netscientific.net.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFAMJTMBBBBBF